The global Composite Artificial Skin Market size is projected to grow from USD 3.97 billion in 2030, also is growing at a CAGR of 4.8% during the forecast period 2022-2030.

Composite Artificial Skin Market Overview:

The composite artificial skin is the largest organ of the human body. While covering such a large area, it is constantly exposed to the outside environment. The skin protects the body from infection and regulates body temperature. But sometimes this outer layer of the body can suffer burns or disease. In these cases, composite artificial skin is used to replace natural human skin.

Sometimes, a person may suffer from a burn so severe that it may be difficult to find any healthy skin on the person that can be used for healing. This is when composite artificial skin is used to treat burns. Composite artificial skin seals open wounds, prevents infection and improves patient survival. Skin conditions such as psoriasis and eczema could also be treated using composite artificial skin. These disorders often cover large areas of the body, and medications containing artificial skin may be more effective than other courses of treatment.

Composite Artificial Skin market size estimates and forecasts are provided in terms of sales volume (K units) and revenue (million USD), with historical and forecast data for the period 2017 to 2030, with 2022 being considered as the base year. This report segments the global Composite Artificial Skin market in detail. Regional market sizes related to products by type, by application, and by player are also delivered. In estimating the size of the market, we took into account the impact of COVID-19 and other global crisis.

A composite artificial skin is a synthetic material that is used to replace or repair skin tissue. It can be used to treat burns, wounds, and other injuries. The importance of composite artificial skin is that it can help improve the quality of life for patients who have suffered severe injuries or burns.

The global Composite Artificial Skin market is the professional and accurate study of various business perspectives such as major key players, key geographies, divers, restraints, opportunities, and challenges. This global research report has been aggregated on the basis of various market segments and sub-segments associated with the global market.

Significant Composite Artificial Skin Market Dynamics and Growth Factors:

"Composite artificial skin replaces animal tests to boost demand"

Animal testing is used as the basis for research in many industries that may need to mimic human skin. Animals experience a lot of pain and discomfort during this test. Most experiments using animal testing produce results that don't even apply to humans. Animal rights groups around the world have been working to end animal testing. Many companies have also stopped using animals for research and started using composite artificial skins. This will augment the growth of the composite artificial skin market in the coming years.

"Growth in the skincare industry spurs demand"

Today, the cosmetics and skincare industry is booming. As people become more sensitive to skin concerns and companies rapidly introduce innovative products, there is a need to test these products to see how well they work and what problems they solve. It is possible to study how the skin is affected by continuous exposure to the sun's harmful UV rays. Another study might be done on how people use products such as sunscreen to protect against these effects. These types of studies do not use real people, but simulated skin, such as composite artificial skin. The skin care industry is one of the major ways in which the composite artificial skin market is expected to grow in the future.

• Integra Life Sciences
• Smith & Nephew
• Organogenesis
• MiMedx
• Tissue Regenix
• Mylan
• Allergan
• PermeaDerm
• Yantai Zhenghai Bio-tech
• Guanhao Biotech
• others

Key Vendors:

1.Integra Life Sciences: Integra is a global leader in neurosurgery and offers a broad portfolio of products and solutions for dural access and repair, cerebral spinal fluid management and neuro-critical care. Our regenerative tissue technologies include products that address soft tissue, nerve and tendon repairs and for the treatment of acute and chronic wounds, burns, as well as for plastic and reconstructive surgery. Integra has expanded its base regenerative technology product portfolio to include surgical instruments, neurosurgical products and advanced wound care products, through global acquisitions and development of new and innovative products and technologies to address unmet patient needs and improve outcomes.

2.Organogenesis: It is a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care.

3.MiMedx:It is an industry leader in advanced wound care and a therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The Company processes the human placental tissue utilizing its proprietary PURION® process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx has supplied more than two million allografts, through both direct and consignment shipments.

4.Tissue Regenix: It is a leading medical devices company in the field of regenerative medicine.The company's patented decellularisation technology removes DNA and other cellular material from animal and human soft tissue leaving an acellular tissue scaffold which is not rejected by the patient's body and can then be used to repair diseased or worn out body parts. Current applications address many critical clinical needs such as sports medicine, heart valve replacement and wound care.

5.Allergan: It is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.

The Composite Artificial Skin market research report is categorized based on type, applications and region.

On the Basis of Type:

• From Animal Cell Tissue
• From Human Tissue

On the Basis of Application:

• Hospitals
• Wound Care Centers
• others

On the Basis of Region:

Geographically, the global Composite Artificial Skin market has been analyzed in various regions such as North America, Latin America, Middle East, Asia-Pacific, Africa, Europe, and India. The global Composite Artificial Skin region is dominating this market in the upcoming future.

North America dominates the composite artificial skin market. Elderly, diabetic and obese populations are increasing in North America. These diseases are associated with chronic wounds. Rising number of patients with chronic wounds in the region has given birth to the composite artificial skin market. Road accidents are also on the rise in North America. Because many traffic accident victims suffer severe burns, treatment involves the use of composite artificial skin.

Europe holds a considerable market share for composite artificial skin. The composite artificial skin market is emerging in the region as the industry undertakes more R&D activities. In addition to increasing R&D, large geriatric population base will boost the growth of the region in the coming years.

Further the regions are divided into countries as follows

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
  • Denmark
  • Finland
  • Iceland
  • Sweden
  • Norway
  • Belgium
  • The Netherlands
  • Luxembourg
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Benelux Union
• Rest of Europe
• Asia-Pacific
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Rest of Southeast Asia
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

DRIVING FACTORS

"Replacement of Animal Testing with Composite Artificial Skin to Boost Demand"

Animal testing is used as a basis for research in a lot of industries where there may be a need to model human skin. During this course of testing, animals suffer a lot and it causes them pain and discomfort. The majority of the experiments conducted using animal testing produce results that don’t even hold true for humans. Animal rights organizations around the world have been making constant efforts to put an end to animal testing. Many companies have also stopped conducting research using animals and started using composite artificial skin. This is going to expand the composite artificial skin market growth in the coming years.

"Growth in the Skin Care Industry to Stimulate Demand"

The cosmetics and skincare industries are booming these days. With people becoming more sensitive about their skin issues and companies coming out with new and innovative products at a rapid rate, there arises a need for testing these products, seeing how well they work, and what problems they solve. Research might be conducted on how the skin is affected by constant exposure to harmful ultraviolet rays of the sun. Another study might be conducted on how products such as sunscreens can be used by people as protection against these effects. These types of research don’t use actual humans but instead, use simulated skin such as composite artificial skin. The skincare industry is one of the major ways why the composite artificial skin market is expected to grow in the future.

TRENDS

"Innovations in Robot-Sensing to Accelerate Growth"

R&D in the field of robotics in healthcare are gaining momentum. A team of researchers at the California Institute of Technology has managed to create a new type of robot, a robot with a sense of touch. This could provide the robot with the ability to touch something and determine the texture, temperature, and if something is a toxic substance. This has been made possible with the use of composite artificial skin. The robot is provided with an arm that has artificial skin and the sensors on the skin are attached to a person. This person senses what the item is and responds accordingly. While this innovation is still in its prototype phase, it has potential applications in industries such as security, agriculture, and environmental protection. Such technological advances will certainly strengthen the market outlook in the future.

RESTRAINING FACTORS

"Expensiveness of Composite Artificial Skin Treatments to Reduce Growth"

While composite artificial skin treatments for burns and wounds are very effective, they are extremely expensive. It might not be possible for people from humble backgrounds to access such treatments. Only a certain section of the population might be able to afford such expenses. This could hamper the composite artificial skin market growth.

Scope of report: